Nuveen’s Immunocore IMCR Stock Holding History

Nuveen’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.6K	Buy	+167	New	+$5.68K	﹤0.01%	4495

Other funds holding IMCR

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Fulcrum Asset Management London, United Kingdom $2.14B AUM 54.66% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $21.9B AUM 28.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Nuveen's IMCR Position: Q3 2026 in Review

Nuveen opened a new position in Immunocore (IMCR) in Q3 2026: 167 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #4495 among its holdings.

39 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

Nuveen held 167 shares of Immunocore worth $12.6K as of Q3 2026.
Immunocore was a new Nuveen position in Q3 2026.
Immunocore made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4495 holding.
39 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.